{"id":38388,"date":"2026-04-14T10:10:21","date_gmt":"2026-04-14T08:10:21","guid":{"rendered":"https:\/\/ggba.swiss\/?p=38388"},"modified":"2026-04-14T10:10:23","modified_gmt":"2026-04-14T08:10:23","slug":"deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/","title":{"rendered":"dEEGtal strengthens governance and advances clinical validation across three continents"},"content":{"rendered":"\n

Geneva-based dEEGtal<\/a>, which develops AI-powered software to improve care in neurology and psychiatry, has appointed Ann Bunnenberg as an independent member of its board of directors. A medical device entrepreneur, venture investor, and lawyer with deep experience in neurotechnology, Bunnenberg brings expertise in product development, international commercialization, and strategic partnerships at a pivotal moment in the company’s development.<\/p>\n\n\n\n

The appointment coincides with a period of significant clinical momentum. dEEGtal has validated its software on data collected from seven epilepsy centers across Europe and the United States in the context of a pre-incorporation academic research project, accumulating pre-clinical evidence on approximately 2,000 patients. The company has since established three active clinical collaborations: a study at a first seizure unit in Basel evaluating the platform in a real-world clinical context; an ongoing study at Vall d’Hebron Hospital in Barcelona targeting approximately 350 patients in an emergency center setting; and a partnership with UTMB in Galveston, Texas, from which its US clinical trials will be led.<\/p>\n\n\n\n

The platform combines large-scale EEG datasets collected across leading European and American clinical centers with advanced AI models, targeting faster and more accurate identification of patients at risk of epilepsy following a first seizure, a critical decision point where current diagnostic tools frequently fall short. The company raised over CHF 1 million in seed funding in December 2024, anchored by a CHF 750,000 contribution from the Wyss Center<\/a> in Geneva.<\/p>\n\n\n\n

A CHF 4\u20135 million seed round is currently open and expected to close in Q2 2026, which will fund US clinical trials and position dEEGtal as a commercial-stage company in that market. Beyond epilepsy, the company plans to extend its large brain signal model to additional neurological and psychiatric conditions.<\/p>\n","protected":false},"excerpt":{"rendered":"

Geneva-based dEEGtal has appointed neurotechnology entrepreneur and investor Ann Bunnenberg to its board of directors, as the AI-powered brain signal platform advances clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.<\/p>\n","protected":false},"author":6,"featured_media":38389,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[893,930,894,963,926,902],"class_list":["post-38388","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-artificial-intelligence","tag-digital-health","tag-financing","tag-medical-devices","tag-medtech","tag-personalized-medicine"],"acf":[],"yoast_head":"\ndEEGtal strengthens governance and advances clinical validation<\/title>\n<meta name=\"description\" content=\"Geneva-based dEEGtal has advanced clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"dEEGtal strengthens governance and advances clinical validation\" \/>\n<meta property=\"og:description\" content=\"Geneva-based dEEGtal has advanced clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-14T08:10:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-14T08:10:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"dEEGtal strengthens governance and advances clinical validation across three continents\",\"datePublished\":\"2026-04-14T08:10:21+00:00\",\"dateModified\":\"2026-04-14T08:10:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\",\"url\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\",\"name\":\"dEEGtal strengthens governance and advances clinical validation\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"datePublished\":\"2026-04-14T08:10:21+00:00\",\"dateModified\":\"2026-04-14T08:10:23+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Geneva-based dEEGtal has advanced clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"dEEGtal's AI platform combines large-scale EEG datasets with clinical data to improve diagnostic and predictive capabilities in neurology and psychiatry, starting with epilepsy care following a first seizure. | \u00a9 dEEGtal\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"dEEGtal strengthens governance and advances clinical validation across three continents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"dEEGtal strengthens governance and advances clinical validation","description":"Geneva-based dEEGtal has advanced clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/","og_locale":"en_US","og_type":"article","og_title":"dEEGtal strengthens governance and advances clinical validation","og_description":"Geneva-based dEEGtal has advanced clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.","og_url":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-04-14T08:10:21+00:00","article_modified_time":"2026-04-14T08:10:23+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"dEEGtal strengthens governance and advances clinical validation across three continents","datePublished":"2026-04-14T08:10:21+00:00","dateModified":"2026-04-14T08:10:23+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/"},"wordCount":288,"image":{"@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","keywords":["Artificial Intelligence","Digital Health","Financing","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/","url":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/","name":"dEEGtal strengthens governance and advances clinical validation","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","datePublished":"2026-04-14T08:10:21+00:00","dateModified":"2026-04-14T08:10:23+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Geneva-based dEEGtal has advanced clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4\u20135 million seed round.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/04\/Deegtal-2026-1180x811-1.jpeg","width":1180,"height":811,"caption":"dEEGtal's AI platform combines large-scale EEG datasets with clinical data to improve diagnostic and predictive capabilities in neurology and psychiatry, starting with epilepsy care following a first seizure. | \u00a9 dEEGtal"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/deegtal-strengthens-governance-and-advances-clinical-validation-across-three-continents\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"dEEGtal strengthens governance and advances clinical validation across three continents"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/38388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=38388"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/38388\/revisions"}],"predecessor-version":[{"id":38392,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/38388\/revisions\/38392"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/38389"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=38388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=38388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=38388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}